DAX 24.897 -2,2%ESt50 6.205 -1,8%MSCI World 4.812 -0,7%Top 10 Crypto 8,12 -3,5%Nas 25.871 +0,2%Bitcoin 54.149 -0,7%Euro 1,1424 +0,0%Öl 78,9 -0,7%Gold 4.062 -0,4%
Beliebte Suche
DAX 40ÖlpreisEuro - DollarBitcoin - EuroGoldpreis
Meistgesucht
BioNTech (ADRs)A2PSR2TeslaA1CX3TAmazon906866NEL ASAA0B733Microsoft870747Apple865985Siemens EnergyENER6YBASFBASF11NVIDIA918422Lufthansa823212Mercedes-Benz Group (ex Daimler)710000BayerBAY001Daimler TruckDTR0CKPlug PowerA1JA81TUITUAG00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero.Hier informieren
Top News
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & MusterdepotsTools & integriertes TradingNewsletter, Trading-Desk uvm.
Schon einen Account? Anmelden

EQS-PVR: Pentixapharm Holding AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Werte in diesem Artikel
Aktien
Pentixapharm Holding AG Unitary
2.02 EUR -0.07 EUR -3.35 %
Charts | News | Analysen
Aktie kaufen

EQS Voting Rights Announcement: Pentixapharm Holding AG
Pentixapharm Holding AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

17.10.2024 / 14:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung

Eckert Wagniskapital und Frühphasenfinanzierung GmbH, Panketal OT Zepernick, Germany informed us on October 15, 2024 pursuant to Art. 43(1) WpHG thereby making reference to the exceedance of the threshold of 10% or a higher threshold from October 03, 2024 , as follows:

  • The investment is used to realize trading profits.
  • The reporting person does intend to obtain further voting rights by acquisition or any other way.
  • The reporting person does intend to influence the composition of the issuers' administration, management or supervisory board.
  • The reporting person does not intend to change the capital structure of the company, especially with regards to the ratio of internal/outside financing and the dividend policy.
  • Concerning the source of funds, the capital is financed by 100% through equity capital with which the reporting person needs to finance the acquisition of the voting rights.


17.10.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Pentixapharm Holding AG
Robert-Rössle-Straße 10
13125 Berlin
Germany
Internet: https://www.pentixapharm.com/

 
End of News EQS News Service
Werbung

2010709  17.10.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2010709&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Aktuelle Pentixapharm Aktie News

Werbung

Pentixapharm Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Pentixapharm nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
26.06.26 Pentixapharm Kaufen BankM AG